Overview

Bioequivalence Study to Compare the Pharmacokinetics of Besifovir in Healthy Adult Volunteers

Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
After administration of besifovir preparations different from each other to healthy subjects, the investigators evaluate equivalence of bioavailability of LB80331.
Phase:
Phase 1
Details
Lead Sponsor:
IlDong Pharmaceutical Co Ltd
Treatments:
Maleic acid